{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:22:06Z","timestamp":1780730526040,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T00:00:00Z","timestamp":1427500800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1193-1","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T02:59:16Z","timestamp":1427597956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prognostic significance of interim PET\/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Sung-Hoon","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sook","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeo-Kyeoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Seog","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joon","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Seung","family":"Bom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeoung-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Soo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Ho","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Kyun","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Hyun","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Rok","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok-Hwan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,28]]},"reference":[{"issue":"5","key":"1193_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/ajh.23144","volume":"87","author":"JO Armitage","year":"2012","unstructured":"Armitage JO. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management. Am J Hematol. 2012;87(5):511\u20139.","journal-title":"Am J Hematol"},{"issue":"5","key":"1193_CR2","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/annonc\/mdn022","volume":"19","author":"S Mercadal","year":"2008","unstructured":"Mercadal S, Briones J, Xicoy B, Pedro C, Escoda L, Estany C, et al. Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol. 2008;19(5):958\u201363.","journal-title":"Ann Oncol"},{"issue":"1","key":"1193_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","volume":"27","author":"P Reimer","year":"2009","unstructured":"Reimer P, Rudiger T, Geissinger E, Weissinger F, Nerl C, Schmitz N, et al. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol. 2009;27(1):106\u201313.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1193_CR4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J, et al. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol. 2007;18(4):652\u20137.","journal-title":"Ann Oncol"},{"issue":"11","key":"1193_CR5","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1200\/JCO.2009.26.5942","volume":"28","author":"CH Moskowitz","year":"2010","unstructured":"Moskowitz CH, Schoder H, Teruya-Feldstein J, Sima C, Iasonos A, Portlock CS, et al. Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma. J Clin Oncol. 2010;28(11):1896\u2013903.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1193_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bbmt.2008.11.026","volume":"15","author":"YL Kasamon","year":"2009","unstructured":"Kasamon YL, Wahl RL, Ziessman HA, Blackford AL, Goodman SN, Fidyk CA, et al. Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning. Bio Blood Marrow Transplant. 2009;15(2):242\u20138.","journal-title":"Bio Blood Marrow Transplant"},{"issue":"3","key":"1193_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1182\/blood-2006-04-019901","volume":"109","author":"EJ Dann","year":"2007","unstructured":"Dann EJ, Bar-Shalom R, Tamir A, Haim N, Ben-Shachar M, Avivi I, et al. Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome. Blood. 2007;109(3):905\u20139.","journal-title":"Blood"},{"issue":"1","key":"1193_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/annonc\/mdp271","volume":"21","author":"A Avigdor","year":"2010","unstructured":"Avigdor A, Bulvik S, Levi I, Dann EJ, Shemtov N, Perez-Avraham G, et al. Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET\/CT scan is an effective regimen for advanced high-risk Hodgkin\u2019s lymphoma. Ann Oncol. 2010;21(1):126\u201332.","journal-title":"Ann Oncol"},{"issue":"11","key":"1193_CR9","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1200\/JCO.2008.16.0861","volume":"27","author":"T Terasawa","year":"2009","unstructured":"Terasawa T, Lau J, Bardet S, Couturier O, Hotta T, Hutchings M, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin\u2019s lymphoma and diffuse large B-cell lymphoma: a systematic review. J Clin Oncol. 2009;27(11):1906\u201314.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1193_CR10","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3109\/10428190903275610","volume":"50","author":"NG Mikhaeel","year":"2009","unstructured":"Mikhaeel NG. Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now? Leuk Lymphoma. 2009;50(12):1931\u20136.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"1193_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2214\/AJR.09.3665","volume":"195","author":"J Feeney","year":"2010","unstructured":"Feeney J, Horwitz S, Gonen M, Schoder H. Characterization of T-cell lymphomas by FDG PET\/CT. AJR Am J Roentgenol. 2010;195(2):333\u201340.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"1193_CR12","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan M, Gallamini A, Haioun C. Report on the First International Workshop on Interim-PET-Scan in Lymphoma. Leuk Lymphoma. 2009;50(8):1257\u201360.","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"1193_CR13","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3109\/10428194.2012.677535","volume":"53","author":"M Meignan","year":"2012","unstructured":"Meignan M, Gallamini A, Itti E, Barrington S, Haioun C, Polliack A. Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26\u201327 September 2011 and Menton 2011 consensus. Leuk Lymphoma. 2012;53(10):1876\u201381.","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"1193_CR14","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2967\/jnumed.110.080556","volume":"51","author":"E Itti","year":"2010","unstructured":"Itti E, Juweid ME, Haioun C, Yeddes I, Hamza-Maaloul F, El Bez I, et al. Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background. J Nucl Med. 2010;51(12):1857\u201362.","journal-title":"J Nucl Med"},{"issue":"4","key":"1193_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2967\/jnumed.108.057703","volume":"50","author":"E Itti","year":"2009","unstructured":"Itti E, Lin C, Dupuis J, Paone G, Capacchione D, Rahmouni A, et al. Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4\u00a0cycles of chemotherapy. J Nucl Med. 2009;50(4):527\u201333.","journal-title":"J Nucl Med"},{"issue":"3","key":"1193_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00259-009-1275-x","volume":"37","author":"T Cazaentre","year":"2010","unstructured":"Cazaentre T, Morschhauser F, Vermandel M, Betrouni N, Prangere T, Steinling M, et al. Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(3):494\u2013504.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1193_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11899-011-0098-6","volume":"6","author":"PL Zinzani","year":"2011","unstructured":"Zinzani PL. PET in T-Cell Lymphoma. Curr Hematol Malig Rep. 2011;6(4):241\u20134.","journal-title":"Curr Hematol Malig Rep"},{"issue":"10","key":"1193_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/annonc\/mdm265","volume":"18","author":"S Kako","year":"2007","unstructured":"Kako S, Izutsu K, Ota Y, Minatani Y, Sugaya M, Momose T, et al. FDG-PET in T-cell and NK-cell neoplasms. Ann Oncol. 2007;18(10):1685\u201390.","journal-title":"Ann Oncol"},{"issue":"1","key":"1193_CR19","first-page":"115","volume":"89","author":"J Valencak","year":"2004","unstructured":"Valencak J, Becherer A, Der-Petrossian M, Trautinger F, Raderer M, Hoffmann M. Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas. Haematologica. 2004;89(1):115\u20136.","journal-title":"Haematologica"},{"issue":"6","key":"1193_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2967\/jnumed.113.131946","volume":"55","author":"PL Khong","year":"2014","unstructured":"Khong PL, Huang B, Phin Lee EY, Sum Chan WK, Kwong YL. Midtreatment 18F-FDG PET\/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer\/T-Cell Lymphoma: A Prospective Study from a Single Center. J Nucl Med. 2014;55(6):911\u20136.","journal-title":"J Nucl Med"},{"issue":"7","key":"1193_CR21","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1634\/theoncologist.2013-0463","volume":"19","author":"C Pellegrini","year":"2014","unstructured":"Pellegrini C, Argnani L, Broccoli A, Stefoni V, Derenzini E, Gandolfi L, et al. Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma. Oncologist. 2014;19(7):746\u201350.","journal-title":"Oncologist"},{"issue":"5","key":"1193_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u201386.","journal-title":"J Clin Oncol."},{"issue":"12","key":"1193_CR23","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3109\/10428194.2010.529208","volume":"51","author":"M Meignan","year":"2010","unstructured":"Meignan M, Gallamini A, Haioun C, Polliack A. Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8\u20139 April 2010. Leuk Lymphoma. 2010;51(12):2171\u201380.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1193_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1179\/174313208X325191","volume":"31","author":"A Rijbroek","year":"2009","unstructured":"Rijbroek A, Boellaard R, Vriens EM, Lammertsma AA, Rauwerda JA. Comparison of transcranial Doppler ultrasonography and positron emission tomography using a three-dimensional template of the middle cerebral artery. Neurol Res. 2009;31(1):52\u20139.","journal-title":"Neurol Res"},{"issue":"3","key":"1193_CR25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.09.039","volume":"67","author":"R Hong","year":"2007","unstructured":"Hong R, Halama J, Bova D, Sethi A, Emami B. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning. Int J Radiat Oncol Biol Phys. 2007;67(3):720\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1193_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.lungcan.2011.01.007","volume":"73","author":"D Zhu","year":"2011","unstructured":"Zhu D, Ma T, Niu Z, Zheng J, Han A, Zhao S, et al. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with small cell lung cancer. Lung Cancer. 2011;73(3):332\u20137.","journal-title":"Lung Cancer"},{"issue":"4","key":"1193_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11307-010-0404-z","volume":"13","author":"X Wu","year":"2011","unstructured":"Wu X, Dastidar P, Pertovaara H, Korkola P, Jarvenpaa R, Rossi M, et al. Early treatment response evaluation in patients with diffuse large B-cell lymphoma\u2013a pilot study comparing volumetric MRI and PET\/CT. Mol Imaging Biol. 2011;13(4):785\u201392.","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"1193_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s12185-013-1444-3","volume":"98","author":"U Tateishi","year":"2013","unstructured":"Tateishi U. PET\/CT in malignant lymphoma: basic information, clinical application, and proposal. Int J Hematol. 2013;98(4):398\u2013405.","journal-title":"Int J Hematol"},{"issue":"9","key":"1193_CR29","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/annonc\/mdf256","volume":"13","author":"K Spaepen","year":"2002","unstructured":"Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, de Groot T, et al. Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin\u2019s lymphoma. Ann Oncol. 2002;13(9):1356\u201363.","journal-title":"Ann Oncol"},{"issue":"4","key":"1193_CR30","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1182\/blood-2005-01-0272","volume":"106","author":"C Haioun","year":"2005","unstructured":"Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, et al. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood. 2005;106(4):1376\u201381.","journal-title":"Blood"},{"issue":"2","key":"1193_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1200\/JCO.2011.38.2648","volume":"30","author":"V Safar","year":"2012","unstructured":"Safar V, Dupuis J, Itti E, Jardin F, Fruchart C, Bardet S, et al. Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab. J Clin Oncol. 2012;30(2):184\u201390.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1193_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/annonc\/mdq415","volume":"22","author":"X Cahu","year":"2011","unstructured":"Cahu X, Bodet-Milin C, Brissot E, Maisonneuve H, Houot R, Morineau N, et al. 18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T\/NK lymphomas: a study from the GOELAMS group. Ann Oncol. 2011;22(3):705\u201311.","journal-title":"Ann Oncol"},{"issue":"4","key":"1193_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2967\/jnumed.112.110262","volume":"54","author":"YJ Li","year":"2013","unstructured":"Li YJ, Li ZM, Xia XY, Huang HQ, Xia ZJ, Lin TY, et al. Prognostic value of interim and posttherapy 18F-FDG PET\/CT in patients with mature T-cell and natural killer cell lymphomas. J Nucl Med. 2013;54(4):507\u201315.","journal-title":"J Nucl Med"},{"issue":"10","key":"1193_CR34","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3109\/10428194.2013.767901","volume":"54","author":"C Casulo","year":"2013","unstructured":"Casulo C, Schoder H, Feeney J, Lim R, Maragulia J, Zelenetz AD, et al. 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma. Leuk Lymphoma. 2013;54(10):2163\u20137.","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"1193_CR35","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00259-010-1546-6","volume":"37","author":"M Meignan","year":"2010","unstructured":"Meignan M. Interim PET, in lymphoma: a step towards standardization. Eur J Nucl Med Mol Imaging. 2010;37(10):1821\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"1193_CR36","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00259-014-2715-9","volume":"41","author":"D Hasenclever","year":"2014","unstructured":"Hasenclever D, Kurch L, Mauz-Korholz C, Elsner A, Georgi T, Wallace H, et al. qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging. 2014;41(7):1301\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1193_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2967\/jnumed.113.130609","volume":"55","author":"C Rossi","year":"2014","unstructured":"Rossi C, Kanoun S, Berriolo-Riedinger A, Dygai-Cochet I, Humbert O, Legouge C, et al. Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients. J Nucl Med. 2014;55(4):569\u201373.","journal-title":"J Nucl Med"},{"issue":"1","key":"1193_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1182\/blood-2010-12-327767","volume":"118","author":"RO Casasnovas","year":"2011","unstructured":"Casasnovas RO, Meignan M, Berriolo-Riedinger A, Bardet S, Julian A, Thieblemont C, et al. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood. 2011;118(1):37\u201343.","journal-title":"Blood"},{"issue":"1","key":"1193_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/10428194.2013.802784","volume":"55","author":"M Meignan","year":"2014","unstructured":"Meignan M, Barrington S, Itti E, Gallamini A, Haioun C, Polliack A. Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3\u20135 October 2012. Leuk Lymphoma. 2014;55(1):31\u20137.","journal-title":"Leuk Lymphoma"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1193-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1193-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:23:19Z","timestamp":1630578199000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1193-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,28]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1193-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,28]]},"assertion":[{"value":"5 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"198"}}